Opus Genetics, Inc. (IRD) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.
Key numbers for Opus Genetics, Inc. (IRD): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.
AllSight quality score: 56/100 — a percentile rank of Opus Genetics, Inc.’s fundamentals against Manufacturing peers, weakest on profitability. A quality ranking, not a price prediction.
| Market cap | $420.1M |
| P / S | 42.6× |
| EV / EBITDA | -7.2× |
| Gross margin | 100.0% |
| Operating margin | -513.5% |
| Net margin | -1091.8% |
| Return on equity | 828.7% |
| ROIC | 75.7% |
| Debt / equity | -2.7× |
| Dividend yield | 0.0% |
Independent of the events above — derived from Opus Genetics, Inc.’s own financial statements and shown as context, never as advice.
About AllSight · Editorial standards & method · Contact